Viemed Healthcare Inc VMD

Healthcare

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).

NDAQ:VMD - Post by User

Viemed Healthcare Inc > Non-Invasive Ventilators Market: CAGR of 12.8% in 2019-2027

<< Previous

Bullboard Posts

Next >>

Comment by stockfyon Jul 14, 2021 1:08am

94 Views

Post# 33540821

RE:Non-Invasive Ventilators Market: CAGR of 12.8% in 2019-2027

Agreed Jack.

stockfy wrote:

Check carefully the news below that underline the fact that Viemed (VMD) has tremendous growth potential in the next years. It's clear that VMD's segment has one of the strongest CAGRs in the healthcare industry in the next years:

https://www.biospace.com/article/non-invasive-ventilators-market-growing-prevalence-of-chronic-respiratory-diseases-and-need-for-improved-critical-care-to-foster-growth/

https://www.prnewswire.com/news-releases/players-compete-to-boost-efficacy-of-non-invasive-devices-for-tapping-revenues-in-mechanical-ventilators-market-valuation-to-expand-at-cagr-of-12-8-during-2019--2027--tmr-301293712.html

I quote this excerpt:

"Globally, the valuation of the mechanical ventilators market was pegged at US$ 1.9 Bn in 2018, and is projected to clock CAGR of 12.8% from 2019 to 2027. By 2027, the valuation is estimated to touch the mark of US$ 5.5 Bn."